263 related articles for article (PubMed ID: 28273116)
1. MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
Kendall EA; Azman AS; Cobelens FG; Dowdy DW
PLoS One; 2017; 12(3):e0172748. PubMed ID: 28273116
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of treating multidrug-resistant tuberculosis.
Resch SC; Salomon JA; Murray M; Weinstein MC
PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
4. Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation.
Espindola AL; Varughese M; Laskowski M; Shoukat A; Heffernan JM; Moghadas SM
Int Health; 2017 Mar; 9(2):80-90. PubMed ID: 28338827
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
Caminero JA
Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
7. Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.
Kendall EA; Fojo AT; Dowdy DW
Lancet Respir Med; 2017 Mar; 5(3):191-199. PubMed ID: 27989591
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
9. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
Trauer JM; Achar J; Parpieva N; Khamraev A; Denholm JT; Falzon D; Jaramillo E; Mesic A; du Cros P; McBryde ES
BMC Med; 2016 Nov; 14(1):187. PubMed ID: 27855693
[TBL] [Abstract][Full Text] [Related]
10. Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
Kendall EA; Shrestha S; Cohen T; Nuermberger E; Dooley KE; Gonzalez-Angulo L; Churchyard GJ; Nahid P; Rich ML; Bansbach C; Forissier T; Lienhardt C; Dowdy DW
PLoS Med; 2017 Jan; 14(1):e1002202. PubMed ID: 28045934
[TBL] [Abstract][Full Text] [Related]
11. Redefining MDR-TB transmission 'hot spots'.
Becerra MC; Bayona J; Freeman J; Farmer PE; Kim JY
Int J Tuberc Lung Dis; 2000 May; 4(5):387-94. PubMed ID: 10815730
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
13. Assessing the transmission risk of multidrug-resistant Mycobacterium tuberculosis epidemics in regions of Taiwan.
Liao CM; Lin YJ
Int J Infect Dis; 2012 Oct; 16(10):e739-47. PubMed ID: 22818291
[TBL] [Abstract][Full Text] [Related]
14. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
15. The imminent threat of multidrug-resistant tuberculosis in Singapore.
Chee CB; Khin-Mar KW; Cutter J; Wang YT
Singapore Med J; 2012 Apr; 53(4):238-40. PubMed ID: 22511044
[TBL] [Abstract][Full Text] [Related]
16. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant tuberculosis surveillance and cascade of care in Madagascar: a five-year (2012-2017) retrospective study.
Knoblauch AM; Grandjean Lapierre S; Randriamanana D; Raherison MS; Rakotoson A; Raholijaona BS; Ravaoarimanga M; Ravololonandriana PE; Rabodoarivelo MS; Ratsirahonana O; Rakotomanana F; Razafindranaivo T; Rasolofo V; Rakotosamimanana N
BMC Med; 2020 Jun; 18(1):173. PubMed ID: 32600414
[TBL] [Abstract][Full Text] [Related]
18. Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.
Trauer JM; Denholm JT; Waseem S; Ragonnet R; McBryde ES
Am J Epidemiol; 2016 Jun; 183(12):1138-48. PubMed ID: 27199387
[TBL] [Abstract][Full Text] [Related]
19. Drug-resistant tuberculosis: past, present, future.
Chiang CY; Centis R; Migliori GB
Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
[TBL] [Abstract][Full Text] [Related]
20. Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.
Seaworth BJ; Griffith DE
Microbiol Spectr; 2017 Mar; 5(2):. PubMed ID: 28361737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
